Active Ingredient & Assay
Each tablet contains Diazepam IP 10 mg formulated with pharmaceutical-grade binders and disintegrants, strictly conforming to IP/BP limits for dissolution, assay (90.0%-110.0%), and content uniformity.
D-CAM-10 is a high-potency Diazepam Tablets IP 10 mg formulation by Blessme, the specialized neurology and psychiatry division of Dellwich Lifescience LLP. Manufactured under strict WHO-GMP compliance, D-CAM-10 provides dependable, potent anxiolytic, anticonvulsant, and profound skeletal muscle relaxant efficacy for hospitals, institutions, and exclusive PCD pharma franchise partners across India.

Detailed pharmaceutical specifications, active API monograph compliance, packaging architecture, and regulatory classifications for D-CAM-10.
Diazepam Tablets IP 10 mg (D-CAM-10) is a potent benzodiazepine oral formulation engineered to deliver robust central nervous system calming, profound skeletal muscle relaxation, and rapid control of acute agitation and convulsive disorders under expert medical guidance.
In-depth clinical and commercial guide on Diazepam Tablets IP 10 mg, marketed as D-CAM-10 by Blessme (Dellwich Lifescience LLP). Features therapeutic indications, mechanism of action, strength comparisons, dosing protocols, and commercial distribution across India.
Diazepam tablet 10 mg represents the higher standard clinical strength of Diazepam IP, a potent 1,4-benzodiazepine agent. By acting selectively on inhibitory pathways within the brain, it provides prompt relief in conditions where standard lower doses prove insufficient.
When physicians and procurement officers search for Diazepam tablet, Diazepam tablets IP, or Diazepam 10 mg tablet, they prioritize reliable bioavailability, dissolution uniformity, and dependable manufacturing. D-CAM-10 is compressed in WHO-GMP certified facilities, ensuring each unit delivers precisely 10 mg of active pharmaceutical ingredient.
Diazepam tablet uses for the 10 mg strength center on severe acute clinical scenarios in neurology, psychiatry, orthopaedics, and intensive care:
Diazepam 10 mg exerts its pharmacological action by selectively binding to the high-affinity benzodiazepine regulatory site located between the alpha and gamma subunits of the GABAA receptor-chloride ion channel macromolecular complex.
This allosteric binding markedly amplifies the affinity of gamma-aminobutyric acid (GABA) for its recognition sites, precipitating a higher frequency of chloride ion channel opening. As negatively charged chloride ions stream intracellularly, the post-synaptic membrane undergoes hyperpolarization. The heightened resting electrical threshold curtails repetitive neuronal discharges across the limbic network, thalamocortical circuits, and spinal reflex arcs, generating robust anxiolysis, sedation, and muscular de-tensioning.
Understanding the clinical differences between 5 mg and 10 mg strengths enables precise prescribing:
Diazepam 10 mg is a potent pharmaceutical and must be administered strictly in compliance with physician instructions:
In the Indian pharmaceutical marketplace (featuring legacy brands like Valium, Calmpose, and Placidox), D-CAM-10 by Blessme has emerged as a front-runner for hospitals, pharmacies, and franchise distributors because of:
Given the potency of the 10 mg strength, medical supervision is mandatory:
Diazepam 10 mg is a potent central nervous system depressant. Concomitant use with alcohol, opioids, or other sedatives creates severe synergistic risks of profound sedation, respiratory depression, coma, and mortality. D-CAM-10 is dispensed strictly against a valid prescription from a registered medical practitioner and licensed wholesale channels.
D-CAM-10 is manufactured in fully validated WHO-GMP, ISO 9001:2015, and Schedule M compliant pharmaceutical facilities, ensuring immaculate batch-to-batch consistency and therapeutic reliability.
Each tablet contains Diazepam IP 10 mg formulated with pharmaceutical-grade binders and disintegrants, strictly conforming to IP/BP limits for dissolution, assay (90.0%-110.0%), and content uniformity.
Encased in 5x4x10 tamper-evident blister strips fabricated with moisture-barrier and light-blocking foils to guarantee long shelf-life stability across varied climatic zones.
Complete analytical dossiers, validated Certificate of Analysis (COA), Material Safety Data Sheet (MSDS), and accelerated stability reports are supplied for institutional tenders and regulatory audits.
Produced in certified cGMP facilities featuring automated high-speed compression, HEPA air filtration, clean-room environmental monitoring, and validated QA/QC release protocols.
As a Schedule H controlled benzodiazepine medication, Diazepam 10 mg requires strict medical supervision, cautious dispensing, and compliance with statutory drug laws.
D-CAM-10 contains Diazepam IP 10 mg per tablet. To be sold by retail on the prescription of a Registered Medical Practitioner only. Do not exceed prescribed duration. Caution is advised when driving motor vehicles or handling complex machinery.
Evidence-based clinical applications for Diazepam 10 mg (D-CAM-10):
Critical monitoring checkpoints for prescribing physicians and dispensing pharmacists:
Dellwich Lifescience LLP is an established pharmaceutical company headquartered in Science City, Ahmedabad, Gujarat, committed to cutting-edge manufacturing, stringent quality assurance, and dependable healthcare distribution. Through our dedicated specialized division, Blessme, we formulate and supply a premier catalog of neuro-psychiatric medications, including D-CAM-10 (Diazepam Tablets IP 10 mg).
We support PCD pharma franchise partners, hospital supply networks, government tenders, and third-party manufacturing clients across all Indian states, with an unwavering focus on regulatory integrity and reliable delivery.
Whether you are seeking D-CAM-10 (Diazepam Tablets IP 10 mg) for exclusive PCD monopoly distributorship, third-party contract manufacturing, or institutional hospital bulk supply, Dellwich Lifescience LLP provides reliable supply channels and competitive B2B margins.
Exclusive territorial distribution rights for D-CAM-10 and the complete Blessme Neuro & Psychiatric portfolio with promotional visual aids, product catalogs, and lucrative margins.
Contract manufacturing solutions for Diazepam 10 mg formulations with flexible batch sizing, prompt turnaround, validated stability profiles, and comprehensive dossier backing.
Institutional supply contracts for psychiatric hospitals, orthopaedic trauma centers, government healthcare bodies, and private medical trusts with pan-India dispatch.
When sourcing Diazepam tablets IP or evaluating dependable diazepam tablet brands in India, D-CAM-10 by Blessme offers unmatched quality, regulatory adherence, and commercial viability.
D-CAM-10 is formulated in certified WHO-GMP units utilizing pharmacopoeial grade Diazepam IP, guaranteeing assay consistency and chemical stability.
Tamper-evident, high-barrier blister strips protect every 10 mg tablet from ambient humidity, sunlight, and mechanical degradation during storage and transit.
Centrally dispatched from Science City, Ahmedabad with full GST invoicing, verified batch COA, and dependable logistics coverage across all Indian states.
Exclusive district-level franchise rights for D-CAM-10 and the entire Blessme Neuro portfolio with promotional tools, visual aids, and MR bags.
Certificates of Analysis (COA), stability testing data, and Material Safety Data Sheets (MSDS) readily available for institutional tenders and hospital audits.
Direct access to Dellwich Lifescience LLP product specialists for quick quotes, customized bulk supply inquiries, and dedicated customer assistance.
Authoritative answers to clinical, commercial, dosage, and regulatory questions regarding Diazepam Tablets IP 10 mg.
Diazepam tablet 10 mg (marketed under the brand name D-CAM-10 by Blessme division of Dellwich Lifescience LLP) is a potent benzodiazepine medication. Each tablet contains Diazepam IP 10 mg, prepared under WHO-GMP guidelines for the management of severe anxiety, reflex and spastic muscle disorders, acute alcohol withdrawal agitation, and adjunctive seizure therapy.
D-CAM-10 is clinically indicated for: (1) severe, debilitating anxiety disorders and acute panic states; (2) intense skeletal muscle spasms caused by local musculoskeletal trauma, spasticity from cerebral palsy, or paraplegia; (3) acute alcohol withdrawal symptoms including delirium tremens, agitation, and motor tremors; (4) oral adjunctive control of recurrent convulsions; and (5) procedural sedation prior to diagnostic or endoscopic interventions.
D-CAM-5 contains 5 mg Diazepam IP, typically used for initial dosage titration, moderate situational anxiety, daytime tranquilization, and mild muscle tightness. D-CAM-10 contains 10 mg Diazepam IP, prescribed when a higher level of tranquilization, profound muscle relaxation, or control of severe alcohol withdrawal agitation and acute spasms is clinically required.
Diazepam 10 mg functions as a positive allosteric modulator of post-synaptic GABA_A receptors in the brain. By enhancing the binding of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA), it opens chloride ion channels, inducing hyperpolarization of neuronal membranes. This lowers neuronal excitability in the limbic system, cerebral cortex, and spinal polysynaptic pathways.
No. In India, Diazepam 10 mg is strictly classified as a Schedule H prescription drug and controlled psychotropic substance. It can only be dispensed against a valid prescription from a registered medical practitioner, under stringent state drug regulatory oversight.
D-CAM-10 is packaged in high-barrier 5x4x10 blister strips (200 tablets per pack), engineered to shield the sensitive formulation from ambient moisture, UV light, and transit friction. Bulk institutional packaging is also supplied for hospital tenders.
D-CAM-10 is marketed and distributed by Dellwich Lifescience LLP, headquartered in Science City, Ahmedabad, Gujarat, under its specialized neurology and psychiatric portfolio 'Blessme Neuro Products'.
Yes. Dellwich Lifescience LLP grants district-wise monopoly PCD pharma franchise opportunities for D-CAM-10 and the complete Blessme Neuro and Psychiatric product catalog, backed with visual aids, product cards, promotional inputs, and fast dispatch.
Dosage is strictly determined by the attending physician. In severe anxiety or acute muscle spasm, 10 mg may be administered 2 to 4 times daily. For alcohol withdrawal, 10 mg is administered 3 to 4 times during the initial 24 hours, followed by downward titration. In elderly patients, lower dosages are strictly advised to avoid ataxia and over-sedation.
Common adverse effects include drowsiness, motor ataxia, fatigue, muscle weakness, and dizziness. Due to its sedative impact, patients must avoid driving or operating machinery. Long-term use may produce tolerance and physical dependence, necessitating gradual tapering under medical direction.
Diazepam 10 mg tablets are affordable essential formulations. For official trade rates, PCD franchise pricing, MOQ criteria, and hospital tender quotations for D-CAM-10, contact Dellwich Lifescience LLP at +91-9909931992 or [email protected].
Yes. Dellwich Lifescience LLP provides comprehensive third-party and contract manufacturing for Diazepam tablets (2 mg, 5 mg, 10 mg) under WHO-GMP compliance, complete with stability dossiers, process validation, and testing documentation.
Diazepam 10 mg must never be combined with alcohol, opioids, or other central nervous system depressants, as this combination significantly increases the risk of fatal respiratory depression. Patients with severe hepatic failure, myasthenia gravis, or acute narrow-angle glaucoma should avoid this medicine.
Yes. Every batch of D-CAM-10 is accompanied by a certified Certificate of Analysis (COA), detailed assay testing, and Material Safety Data Sheet (MSDS) to ensure regulatory compliance for clinical audits and institutional procurement.
Connect directly with Dellwich Lifescience LLP for trade pricing, district monopoly PCD rights, third-party manufacturing, or institutional hospital tender supplies.
Get bulk pricing, PCD monopoly availability, and technical documentation for Diazepam 10 mg.